Cargando…
Efficacy and safety of bevacizumab in patients with malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative clinical studies
Background: Malignant melanoma is a highly aggressive cancer that spreads and metastasizes quickly. In recent years, the antiangiogenic drug bevacizumab has been trialed to treat malignant melanoma. We conducted the first meta-analysis to examine the efficacy and safety of bevacizumab combined with...
Autores principales: | Han, Xiao, Ge, Pu, Liu, Siyu, Yang, Dandan, Zhang, Jinzi, Wang, Xinpei, Liang, Weiting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374288/ https://www.ncbi.nlm.nih.gov/pubmed/37521468 http://dx.doi.org/10.3389/fphar.2023.1163805 |
Ejemplares similares
-
Efficacy, safety, and cost-effectiveness analysis of aflibercept in metastatic colorectal cancer: A rapid health technology assessment
por: Ge, Pu, et al.
Publicado: (2022) -
Electrochemotherapy of skin metastases from malignant melanoma: a PRISMA-compliant systematic review
por: Ferioli, Martina, et al.
Publicado: (2022) -
The efficacy and safety of epinephrine for postoperative bleeding in total joint arthroplasty: A PRISMA-compliant meta-analysis
por: Teng, Yanbin, et al.
Publicado: (2017) -
Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis
por: Liang, Hui-ling, et al.
Publicado: (2017) -
Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis
por: Liao, Weiting, et al.
Publicado: (2022)